Eli Lilly & Co. urged doctors to prescribe Zyprexa for elderly patients with dementia, an unapproved use for the antipsychotic, even though the drugmaker had evidence the medicine didn’t work for such patients, according to unsealed internal company documents.
In 1999, four years after Lilly sent study results to the U.S. Food and Drug Administration showing Zyprexa didn’t alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.
Lilly Sold Drug for Dementia Knowing It Didn’t Help, Files Show
The Department of Health and Human Services is freezing all childcare payments to all states, an...
The Trump administration is facing a legal complaint from a group of government employees affected by...
Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —...
